samedan logo
 
 
 
spacer
home > pmps > summer 2019 > why automate?
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Why Automate?

There are many answers to the question 'why automate?', but the bottom line is: if you don’t, you will be left behind. Automation in the pharmaceutical industry affects costs, regulatory compliance, and productivity, so why do we need it?

Data, reproducibility, compliance, and, most importantly, reduction of human error. Can a machine make an error? Of course, it’s called a malfunction. Usually, it is the human who programmed the machine that caused it, so maintenance teams can help provide technical support to make sure the automated process is programmed correctly.

Once the system is set, there are fewer chances for deviation. Automation also provides an opportunity for round-the-clock work because machines do not need to take a break. The benefits of back-up cloud data and encryptions also provide secure systems that can be implemented globally without the need to retrain or reprogram your operations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

spacer
Randice Altschul
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ADM Supports Clinical Trial into Effects of Probiotic Supplements for COVID-19 Patients in Hospital Care

ADM and Hospital de Sagunto, one of the largest medical centers in the Valencia region, today announce their partnership for a clinical trial into the effects of using a food supplement containing live microbial strains to promote gut microbiome balance and help improve health functions related to outcomes for COVID-19 patients in high-risk groups. On 18th March Dr Xavier Cortés, gastroenterologist at Hospital de Sagunto, communicated with medical staff in China who had observed that many COVID-19 patients had exhibited abnormal changes in their gut microbiome.
More info >>

White Papers

The Rare Disease Patients Experience

When planning a clinical trial for a rare disease, it is important to have a holistic understanding of your patient population. You want to be aware of where your patients are coming from, and what it is like to walk in their shoes. These patients need your trial just as much as you need them; even from the earliest stages, conceptualize your rare disease trial as an altruistic relationship between the patient population and your study.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement